• OPEN AN ACCOUNT
Indian Indices
Sensex
81,592.45 -318.56
( -0.39%)
Global Indices
Nasdaq
52,349.65 31.56
(0.06%)
Dow Jones
7,578.06 -35.34
(-0.46%)
Hang Seng
61,109.24 289.88
(0.48%)
Nikkei 225
10,906.25 43.16
(0.40%)
Forex
USD-INR
93.92 0.20
(0.22%)
EUR-INR
104.00 -0.26
(-0.25%)
GBP-INR
124.47 -0.25
(-0.20%)
JPY-INR
0.59 0.00
(-0.08%)

EQUITY - MARKET SCREENER

Visaka Industries Ltd
Industry :  Cement Products
BSE Code
ISIN Demat
Book Value()
509055
INE392A01021
96.6998638
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
VISAKAIND
11
742.3
EPS(TTM)
Face Value()
Div & Yield %
7.81
2
1.4
 

Strides Pharma Science consolidated net profit rises 2.60% in the September 2026 quarter
Oct 30,2026
Net profit of Strides Pharma Science rose 2.60% to Rs 130.84 crore in the quarter ended September 2026 as against Rs 127.53 crore during the previous quarter ended September 2025. Sales rose 17.11% to Rs 1429.73 crore in the quarter ended September 2026 as against Rs 1220.83 crore during the previous quarter ended September 2025.

ParticularsQuarter Ended
Sep. 2026Sep. 2025% Var.
Sales1429.731220.83 17
OPM %17.5518.88 -
PBDT209.35211.53 -1
PBT152.14161.89 -6
NP130.84127.53 3